Seroprevalence of hepatitis B, hepatitis C and HIV among male injecting drug users in Afghanistan
Eastern Mediterranean Health Journal · 05.03.2026 · 32 (2) · 61-68
DOI: 10.26719/2026.32.2.61 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eastern Mediterranean Health Journal, online erschienen am 05.03.2026. Verfasst von Mir S Hakim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Afghanistan Field Epidemiology Training Program, ANPHI, EMPHNET, Central Blood Bank, Kabul, Afgahanistan. Hauptthemen laut MEDLINE: Hepatitis C, Hepatitis B, Substance Abuse, Intravenous, HIV Infections. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Background
Viral hepatitis and HIV infections are common public health concerns among injecting drug users, however, there is limited evidence on their seroprevalence in Afghanistan.
Aim
To determine the seroprevalence of hepatitis B, hepatitis C and HIV among male injecting drug users at Ibn Sina Drug Addiction Treatment Hospital, Kabul, Afghanistan.
Methods
Using a structured questionnaire, we interviewed 397 injecting drug users at Ibn Sina Drug Addiction Treatment Hospital, Kabul, Afghanistan, between November and December 2022. We collected and tested 3–5 ml blood samples from the participants. We analysed the data using Epi Info version 7.2.1 and used binary logistic regression and χ2 tests to identify potential predictors of blood-borne hepatitis B, hepatitis C and HIV infections.
Results
Of the total participants, seroprevalence of hepatitis B was 3.79%, hepatitis C 2.77% and HIV 0.50%. Syringe reuse (10%), sharing of syringes (18.6%) and history of blood transfusion (20.2%) were common, but there was no statistically significant association between these predictors and infection (P < 0.05). However, using shared blades was positively associated with hepatitis B infection.
Conclusion
Although hepatitis B, hepatitis C and HIV seroprevalence were lower in our study than in previous studies, and no significant association was found between the risk factors and these diseases, there is a need to expand harm reduction services beyond needle-syringe programmes to include non-syringe components. The association between shared blade use and hepatitis B infection indicates that harm reduction efforts should also incorporate safe shaving practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Afghanistan Field Epidemiology Training Program, ANPHI, EMPHNET, Central Blood Bank, Kabul, Afgahanistan.
- Afghanistan Field Epidemiology Training Program Cohort III, ANPHI, Kabul, Afgahanistan.
- Afghanistan EMPHNET Country Office, Kabul, Afgahanistan.
- World Health Organization Country Office for Afghanistan.
Förderung
- World Health Organization
Zitieren
APA
Hakim, M. S., Hashimi, M. H., Saeed, K. M., Naeemi, S., Safi, F., Sayedzai, S. A., Jalil, H., Noorzai, D. K., Ahmadzai, S. A., & Amiri, A. W. (2026). Seroprevalence of hepatitis B, hepatitis C and HIV among male injecting drug users in Afghanistan. Eastern Mediterranean Health Journal, 32(2), 61-68. https://doi.org/10.26719/2026.32.2.61
Vancouver
Hakim MS, Hashimi MH, Saeed KM, Naeemi S, Safi F, Sayedzai SA, et al. Seroprevalence of hepatitis B, hepatitis C and HIV among male injecting drug users in Afghanistan. Eastern Mediterranean Health Journal. 2026;32(2):61-68. doi:10.26719/2026.32.2.61
BibTeX
@article{Hakim2026,
author = {Hakim, Mir S and Hashimi, Mohammad H and Saeed, Khwaja Mi and Naeemi, Shoaib and Safi, Faridullah and Sayedzai, Sayed A and Jalil, Hizbullah and Noorzai, Delawar K and Ahmadzai, Sharif Ah and Amiri, Abdul W},
title = {Seroprevalence of hepatitis B, hepatitis C and HIV among male injecting drug users in Afghanistan},
journal = {Eastern Mediterranean Health Journal},
year = {2026},
volume = {32},
number = {2},
pages = {61--68},
doi = {10.26719/2026.32.2.61}
}
EUVIMED